Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

Clinical trial NCT02688790 · TERMINATED

Trial details

NCT number: NCT02688790
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infections

Start date: 2016-04-01
Primary completion: 2019-04-03
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.